Home >

National Development And Reform Commission Plans Unified Pricing Of Basic Medicine

2011/8/20 10:39:00 42

??? 日本語 Fran?ais English 中文

National Development And Reform Commission's Unified Pricing Of Medicine

The Ministry of health planning finance division recently told reporters that since the implementation of the basic medical directory in 2010, it has covered 28 provinces, including 98% of the government run grass-roots medical institutions nationwide.

At the same time, the national development and Reform Commission and other relevant departments are implementing a new pricing mechanism for essential drugs.

Reporters learned that last week, the state

Development and Reform Commission

The relevant departments went to Hayao to conduct research, and held discussions on the unified pricing of some pharmaceuticals in the basic medicine catalogue, and widely sought the views of the industry.

According to the participants, the first batch of varieties expected to achieve national pricing is tentatively scheduled for 41.

A pharmaceutical industry analyst told reporters that the principle of selecting uniform pricing varieties is that the products of the national essential medicines list will be unified in price by stages.

The relevant leaders of the Ministry of planning and finance of the Ministry of Health said that for many varieties of basic drugs that were tendered for many times, with sufficient supply and stable prices, the unified sales price and unified pricing will be determined by the state.

"Future tenders will be turned into quality and services, not price."

She said.

However, reporters also learned that basic medicine

Tendering

In the process of implementation, each province adopts its own procurement system.

Anhui's first implementation of the "low price winning bid" mode has been popularized throughout the country.

According to the briefing, the only reason for "winning the bidding at a low price" is that the enterprise is not profitable and there are many problems in quality control.

In May of this year, Sichuan province's "base medicine king" pharmaceutical scandal broke out in the middle of Sichuan, and the winning bid system of basic medicine began to attract the attention of the relevant departments.

In the view of Yu Mingde, President of the Chinese Pharmaceutical Enterprise Management Association, under the system of winning the bid at a low price, the composition of drugs is not pure and the effect of drug reduction has occurred frequently.

From the national development and Reform Commission website 15 news, the national development and Reform Commission Price Appraisal Center has held a unified pricing forum in Beijing on August 11th and 12 respectively, which makes the industry full of expectations for unified pricing.

"This initiative will return to drugs.

Price

The basic principle is quality first and price reasonable. "

A deputy general manager of a pharmaceutical manufacturing enterprise told reporters, "the basic drug bidding system has become a dilemma for many enterprises.

If we win the bid, there will be no profit for the company, and many times it will be sold at a loss. If we do not participate in the bidding, the market will be lost for many years and the losses will be very heavy. "

Song Dacai, director of the price department of the NDRC price department, said that if some of the essential drugs are unified nationwide, the pharmaceutical industry will be pformed from price competition to quality and service competition in the future.